ES2674177T3 - Preparación de suero - Google Patents

Preparación de suero Download PDF

Info

Publication number
ES2674177T3
ES2674177T3 ES11826220.3T ES11826220T ES2674177T3 ES 2674177 T3 ES2674177 T3 ES 2674177T3 ES 11826220 T ES11826220 T ES 11826220T ES 2674177 T3 ES2674177 T3 ES 2674177T3
Authority
ES
Spain
Prior art keywords
serum preparation
purified
preparation
prothrombin activator
coagulation composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11826220.3T
Other languages
English (en)
Inventor
Paul Masci
John De Jersey
Martin Lavin
Julie Phillips
Goce Dimeski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Q Sera Pty Ltd
Q-Sera Pty Ltd
Original Assignee
Q Sera Pty Ltd
Q-Sera Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010904233A external-priority patent/AU2010904233A0/en
Application filed by Q Sera Pty Ltd, Q-Sera Pty Ltd filed Critical Q Sera Pty Ltd
Application granted granted Critical
Publication of ES2674177T3 publication Critical patent/ES2674177T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Uso de una composición de coagulación en la preparación de una muestra de suero para la detección de analitos, en el que la composición de coagulación consiste esencialmente en activador de la protrombina purificado o comprende activador de la protrombina purificado o parcialmente purificado de veneno de serpiente.
ES11826220.3T 2010-09-20 2011-09-20 Preparación de suero Active ES2674177T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2010904233 2010-09-20
AU2010904233A AU2010904233A0 (en) 2010-09-20 Serum Preparation
PCT/AU2011/001221 WO2012037609A1 (en) 2010-09-20 2011-09-20 Serum preparation

Publications (1)

Publication Number Publication Date
ES2674177T3 true ES2674177T3 (es) 2018-06-27

Family

ID=45873310

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11826220.3T Active ES2674177T3 (es) 2010-09-20 2011-09-20 Preparación de suero

Country Status (15)

Country Link
US (2) US10385381B2 (es)
EP (1) EP2619540B1 (es)
JP (2) JP6133777B2 (es)
KR (1) KR102098083B1 (es)
CN (2) CN107870246B (es)
AU (2) AU2011305058A1 (es)
BR (1) BR112013006444B8 (es)
CA (1) CA2811822C (es)
DK (1) DK2619540T3 (es)
ES (1) ES2674177T3 (es)
IL (1) IL225346B (es)
MX (1) MX351846B (es)
RU (1) RU2643957C2 (es)
WO (1) WO2012037609A1 (es)
ZA (1) ZA201302160B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103513023A (zh) * 2012-06-20 2014-01-15 江苏英诺华医疗技术有限公司 一种以edta抗凝血进行凝血相关功能检测的方法
AU2015336925B2 (en) * 2014-10-23 2020-11-26 Q-Sera Pty Ltd Improved clotting composition
WO2016137431A1 (en) * 2015-02-23 2016-09-01 Nantpharma, Llc Robust methods for determining heparin concentrations
CA3005026A1 (en) * 2015-11-11 2017-05-18 Ethicon, Inc. Sealant formulation and uses thereof
ITUB20160205A1 (it) * 2016-02-05 2017-08-05 Andrea Dominijanni Metodo di preparazione di sangue periferico per l’ottenimento di un preparato con alte concentrazioni di fattori di crescita
CN106248919B (zh) * 2016-07-15 2018-11-06 重庆鼎润医疗器械有限责任公司 基于血样振动检测凝血状态的方法
CN106404483A (zh) * 2016-08-31 2017-02-15 上海科华生物工程股份有限公司 一种血清的制备方法
EP3427833A1 (en) * 2017-07-10 2019-01-16 Victor Lind A device for test preparation of blood for determination of glucose concentration in blood plasma
CN110501504B (zh) * 2018-05-16 2024-03-12 深圳市理邦精密仪器股份有限公司 血液含量检测方法和系统
CN114302761A (zh) * 2019-05-09 2022-04-08 特鲁维安科学公司 逆转血小板聚集的方法和组合物
US20210215724A1 (en) * 2020-01-10 2021-07-15 Oklahoma Blood Institute Method of treating plasma for use
IL273876B2 (en) * 2020-04-07 2024-02-01 Reddress Ltd A method and system for creating a coagulated blood-based dressing, and a connection device that enables this

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57142561A (en) * 1981-02-28 1982-09-03 Masaaki Makino Blood coagulation promoting agent for serum separation and its manufacture
SU1146002A1 (ru) * 1983-07-13 1985-03-23 Алтайский государственный медицинский институт им.Ленинского комсомола Способ количественного определени фибриногена в плазме крови
JPS6153567A (ja) * 1984-08-24 1986-03-17 Nippon Hebizoku Gakujiyutsu Kenkyusho ヒメハブ毒からの血清分離用血液凝固促進剤の製造法
NL8902406A (nl) * 1989-09-27 1991-04-16 Hendrik Coenraad Hemker Prof D Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit.
US5089415A (en) 1990-09-17 1992-02-18 International Technidyne Corp. Method for clotting heparized blood by the addition of protamine, thrombin and snake venom
JPH05157747A (ja) 1991-12-06 1993-06-25 Nissho Corp 採血管
EP0585504A1 (en) * 1992-09-04 1994-03-09 Pentapharm A.G. Phospholipid dependant prothrombin activator and its use in lupus anticoagulant testing
US5736033A (en) 1995-12-13 1998-04-07 Coleman; Charles M. Separator float for blood collection tubes with water swellable material
JP3401162B2 (ja) 1996-11-21 2003-04-28 積水化学工業株式会社 血液凝固促進剤及び血液検査用容器
DE19749197A1 (de) * 1997-11-07 1999-05-12 Dade Behring Marburg Gmbh Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe
JP2000033081A (ja) * 1998-05-13 2000-02-02 Sekisui Chem Co Ltd 血液検査用容器
JP2000046825A (ja) * 1998-05-26 2000-02-18 Sekisui Chem Co Ltd 血液検査用容器
JP2000070241A (ja) * 1998-08-31 2000-03-07 Nissho Corp 急速凝固用真空採血管
JP2000083934A (ja) 1998-09-14 2000-03-28 Medical Link Kk 採血管
US6562837B1 (en) * 1998-10-21 2003-05-13 Korea Institute Of Science & Technology Use of tetrahydroisoquinoline compounds for the treatment of septicemia
JP2001289842A (ja) * 2000-04-10 2001-10-19 Sekisui Chem Co Ltd 血液検査用容器
US6686204B2 (en) * 2001-08-27 2004-02-03 Becton, Dickinson & Company Collection device
BRPI0200269B1 (pt) * 2002-01-31 2016-07-26 Ana Marisa Chudzinski-Tavassi processo de purificação de proteínas solúveis das cerdas da l. obliqua com atividade ativadora de protrombina e uso da fração proteica
US7745192B2 (en) * 2002-04-03 2010-06-29 Venomics Pty Limited Prothrombin activating protein
US20080086085A1 (en) * 2004-05-03 2008-04-10 Leroy Brown Blood drawing device with flash detection
CN101379084A (zh) * 2005-08-05 2009-03-04 新加坡国立大学 新的抗凝血多肽及复合物
UA14516U (en) 2005-11-30 2006-05-15 Nat Univ Food Technologies Vacuum-apparatus for crystallization of solutions
GB2433592A (en) * 2005-12-23 2007-06-27 Pentapharm Ag Assay for thrombin inhibitors
CN101173003A (zh) * 2006-11-03 2008-05-07 中国科学院上海生命科学研究院 尖吻蝮蛇毒凝血酶原激活剂、其编码序列及用途
US20110053851A1 (en) 2007-12-20 2011-03-03 The University Of Queensland Haemostasis-modulating compositions and uses therefor
CN101614736A (zh) * 2008-06-27 2009-12-30 北京华大吉比爱生物技术有限公司 应用新型全血样品垫处理方法的免疫层析检测试剂盒
WO2010024325A1 (ja) * 2008-08-28 2010-03-04 積水メディカル株式会社 血液採取容器
CN201356558Y (zh) * 2009-01-21 2009-12-09 威海鸿宇医疗器械有限公司 中空加胶真空采血管

Also Published As

Publication number Publication date
CN107870246A (zh) 2018-04-03
JP2013537308A (ja) 2013-09-30
BR112013006444B8 (pt) 2021-03-09
MX2013003116A (es) 2013-08-29
RU2643957C2 (ru) 2018-02-06
ZA201302160B (en) 2019-06-26
EP2619540A4 (en) 2014-04-09
AU2015238915A1 (en) 2015-10-29
BR112013006444B1 (pt) 2020-12-15
US20190390248A1 (en) 2019-12-26
KR20140014071A (ko) 2014-02-05
CA2811822A1 (en) 2012-03-29
US20130273584A1 (en) 2013-10-17
EP2619540A1 (en) 2013-07-31
AU2011305058A1 (en) 2013-05-02
BR112013006444A2 (pt) 2016-07-26
JP6419886B2 (ja) 2018-11-07
JP2017161539A (ja) 2017-09-14
IL225346B (en) 2020-09-30
EP2619540B1 (en) 2018-03-21
MX351846B (es) 2017-10-31
DK2619540T3 (en) 2018-06-25
CN103403519B (zh) 2018-02-02
IL225346A0 (en) 2013-06-27
WO2012037609A1 (en) 2012-03-29
KR102098083B1 (ko) 2020-04-08
JP6133777B2 (ja) 2017-05-24
CN103403519A (zh) 2013-11-20
CN107870246B (zh) 2021-04-09
BR112013006444A8 (pt) 2019-04-16
CA2811822C (en) 2019-12-03
US10385381B2 (en) 2019-08-20
AU2015238915B2 (en) 2017-07-20
RU2013118341A (ru) 2014-10-27

Similar Documents

Publication Publication Date Title
ES2674177T3 (es) Preparación de suero
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
EP4249605A3 (en) Methods for analyte detection
BR112013025758A2 (pt) monitoramento de misturas de amplificação de recombinase polimerase
BR112013017080A2 (pt) Anticorpo ou fragmento funcional do mesmo que se liga a forma ativa de calicreína do plasma humano, composiçao farmacêutica e método de detecçao de calicreína do plasma em um paciente
BRPI1013688A8 (pt) Proteínas de ligação de il-17.
WO2010132453A3 (en) Methods and compositions for analyte detection
WO2014074648A3 (en) Riboregulator compositions and methods of use
SG169968A1 (en) Adhesive composition for use in an immunosensor
CL2012002741A1 (es) Metodo para determinar en una muestra de sangre la presencia de vitamina d libre; inmunoensayo para detrminar presencia de vitamina d libre en sangre; kit para efectuar inmunoensayo.
GB201200658D0 (en) Methods,compositions,and kits for determining the presence/absence of a variant nucleic acid sequence
BRPI1011886A2 (pt) solução contendo ácido hiplocloroso e métodos do uso do mesmo.
DE602006015793D1 (de) Proteolipidmembran und lipidmembranen-biosensor
BR112016008970A2 (pt) Método de ativação ex vivo e para avaliar ativação plasmática em um indivíduo, ensaio ex vivo para determinar atividade de calicreína plasmática em uma amostra
WO2014005125A3 (en) Fluorescent compounds and uses thereof
PE20131401A1 (es) Kit para detectar el virus de la leucemia bovina (blv), y uso del mismo
AR067135A1 (es) Metodos para aislar arn de fragmento largo de muestras fijas
WO2009018112A3 (en) The use of novel coumarins as glutathione and thiol labels
MX2012009908A (es) Ensayos y equipos para la serotipificacion de pseudomas aeruginosa y secuencias de oligonucleotido utiles en dichos metodos y equipos.
NO20084320L (no) Antistoffer mot EGFL7 og fremgangsmater for anvendelse av disse
MX2013004230A (es) Uso de compuestos mejoradores de señal en deteccion de electroquimioluminiscencia.
BR112014032916A2 (pt) anticorpos anti-fármacos e usos destes para o monitoramento de fármaco
BR112014031958A2 (pt) bag3 como marcador de tecido e soro bioquímico
BR112013000840A2 (pt) método para aumentar o efeito de forma ativada potencializada de anticorpo para molécula endógena biológica, composição farmacêutica e uso de combinação de molécula biológica endógena com forma ativada potencializada de anticorpo para a sintase no endotelial.
WO2012164525A3 (en) Aging biomarkers